Association of non-invasive liver-related scores with cardiovascular disease and a four-domain cardiovascular-renal-hepatic-metabolic phenotype in patients with type 2 diabetes mellitus and MASLD

Endocrine. 2026 Aug 15;91(1):276. doi: 10.1007/s12020-026-04751-z.ABSTRACTOBJECTIVE: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a systemic disorder associated with cardiovascular, renal, and metabolic comorbidities. We evaluated cardiovascular disease (CVD), four-domain card

K Katerina Stefanaki

Mitochondrial Omics in Macrophage Foam Cell Formation and Atherosclerosis

Proteomics. 2026 Aug 15:e70172. doi: 10.1002/pmic.70172. Online ahead of print.ABSTRACTAtherosclerotic cardiovascular disease (ASCVD) is a leading cause of death worldwide, with atherosclerosis serving as the core pathological mechanism driving ischemic heart disease, ischemic stroke, and peripheral

E Enhui Wu